Your browser doesn't support javascript.
loading
Obesity-associated changes in molecular biology of primary breast cancer.
Nguyen, Ha-Linh; Geukens, Tatjana; Maetens, Marion; Aparicio, Samuel; Bassez, Ayse; Borg, Ake; Brock, Jane; Broeks, Annegien; Caldas, Carlos; Cardoso, Fatima; De Schepper, Maxim; Delorenzi, Mauro; Drukker, Caroline A; Glas, Annuska M; Green, Andrew R; Isnaldi, Edoardo; Eyfjörð, Jórunn; Khout, Hazem; Knappskog, Stian; Krishnamurthy, Savitri; Lakhani, Sunil R; Langerod, Anita; Martens, John W M; McCart Reed, Amy E; Murphy, Leigh; Naulaerts, Stefan; Nik-Zainal, Serena; Nevelsteen, Ines; Neven, Patrick; Piccart, Martine; Poncet, Coralie; Punie, Kevin; Purdie, Colin; Rakha, Emad A; Richardson, Andrea; Rutgers, Emiel; Vincent-Salomon, Anne; Simpson, Peter T; Schmidt, Marjanka K; Sotiriou, Christos; Span, Paul N; Tan, Kiat Tee Benita; Thompson, Alastair; Tommasi, Stefania; Van Baelen, Karen; Van de Vijver, Marc; Van Laere, Steven; Van't Veer, Laura; Viale, Giuseppe; Viari, Alain.
Afiliación
  • Nguyen HL; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Geukens T; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Maetens M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Aparicio S; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada.
  • Bassez A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Borg A; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.
  • Brock J; VIB Center for Cancer Biology, Leuven, Belgium.
  • Broeks A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden.
  • Caldas C; Lund University Cancer Center Lund, Lund, Sweden.
  • Cardoso F; CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden.
  • De Schepper M; Department of Clinical Sciences, SCIBLU Genomics, Lund University, Lund, Sweden.
  • Delorenzi M; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Drukker CA; Departments of Core Facility, Molecular Pathology and Biobanking, Antoni van Leeuwenhoek, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Glas AM; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
  • Green AR; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.
  • Isnaldi E; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Eyfjörð J; Department of Oncology, University of Lausanne, Epalinges, Switzerland.
  • Khout H; SIB Swiss Institute of Bioinformatics, Bioinformatics Core Facility, Lausanne, Switzerland.
  • Knappskog S; Department of Surgical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Krishnamurthy S; Agendia, Amsterdam, the Netherlands.
  • Lakhani SR; Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Langerod A; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Martens JWM; BioMedical Center, School of Health Sciences, Faculty of Medicine, University of Iceland, Reykjavík, Iceland.
  • McCart Reed AE; Department of Breast Surgery, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Murphy L; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.
  • Naulaerts S; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Nik-Zainal S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nevelsteen I; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.
  • Neven P; Pathology Queensland, The Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
  • Piccart M; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen, Oslo, Norway.
  • Poncet C; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Punie K; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.
  • Purdie C; University of Manitoba and Cancer Care Manitoba Research Institute, Winnipeg, MB, Canada.
  • Rakha EA; Laboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium.
  • Richardson A; Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Rutgers E; MRC Cancer Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Vincent-Salomon A; Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Simpson PT; Department of Gynecological Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Schmidt MK; Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium.
  • Sotiriou C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Span PN; Department of General Medical Oncology and Multidisciplinary Breast Unit, Leuven Cancer Institute and University Hospitals Leuven, Leuven, Belgium.
  • Tan KTB; Department of Pathology, University of Dundee, NHS Tayside, Dundee, UK.
  • Thompson A; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.
  • Tommasi S; Department of Histopathology, Nottingham University Hospital NHS Trust, City Hospital Campus, Nottingham, UK.
  • Van Baelen K; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Van de Vijver M; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Van Laere S; Diagnostic and Theranostic Medicine Division, Institut Curie, PSL Research University, Paris, France.
  • Van't Veer L; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.
  • Viale G; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Viari A; Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium.
Nat Commun ; 14(1): 4418, 2023 07 21.
Article en En | MEDLINE | ID: mdl-37479706
ABSTRACT
Obesity is associated with an increased risk of developing breast cancer (BC) and worse prognosis in BC patients, yet its impact on BC biology remains understudied in humans. This study investigates how the biology of untreated primary BC differs according to patients' body mass index (BMI) using data from >2,000 patients. We identify several genomic alterations that are differentially prevalent in overweight or obese patients compared to lean patients. We report evidence supporting an ageing accelerating effect of obesity at the genetic level. We show that BMI-associated differences in bulk transcriptomic profile are subtle, while single cell profiling allows detection of more pronounced changes in different cell compartments. These analyses further reveal an elevated and unresolved inflammation of the BC tumor microenvironment associated with obesity, with distinct characteristics contingent on the estrogen receptor status. Collectively, our analyses imply that obesity is associated with an inflammaging-like phenotype. We conclude that patient adiposity may play a significant role in the heterogeneity of BC and should be considered for BC treatment tailoring.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Bélgica